News

The renal phosphate wasting disease X-linked hypophosphatemia (XLH) is a rare metabolic disorder of the bones associated with severe renal phosphate loss. The first symptoms of the genetic defect appear in childhood and adolescence and can…

The appearance of gene therapy on the body's genetic map for cancer cells_AdobeStock_1151217184

The German Research Foundation (DFG) is funding the SCOPE-AI project with approximately €330,000. Researchers from Helmholtz Munich, Helmholtz AI, Philipps-Universität Marburg, and the German Cancer Research Center (DKFZ) aim to create one of the…

EASD 2026 - Award Anette-Gabriele Ziegler

Three scientists from Helmholtz Munich and the German Center for Diabetes Research (DZD) were honored with prestigious awards at the annual meeting of the European Association for the Study of Diabetes (EASD) from September 28 to October 2, 2026, in…

Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at Ludwig-Maximilians-Universität München (LMU), has received the 2026 Gill Transformative Investigator Award. With this distinction, the Gill…

News

News

Mass spectrometry imaging provides new insights into X-linked hypophosphatemia

People & Grants

Mini-Organs and Big Data: How AI Is Advancing Organoid Research

Triple Recognition for Diabetes Research at Helmholtz Munich

Timo Müller Receives 2026 Gill Transformative Investigator Award

Press Contact